Cerebras just learned what the market really cares about: not AI hype, not triple-digit narrative energy, but whether the economics can hold up under scale. The company posted a strong first public earnings report on revenue, yet the stock was punished because management immediately reset expectations on profitability. That reaction makes sense. A semiconductor name trading at 182.26x earnings and 67.26x sales does not get the benefit of the doubt when core gross margin is guided from 47% in Q1 down to 36%-38% in Q2.
The cleanest reason to stay bearish is that the quarter's headline strength was overshadowed by a sharp margin comedown straight from management. Q1 FY2026 core revenue rose 92% year over year to $191.3 million, and GAAP revenue climbed 94% to $193.4 million, which should have been enough to support the stock. Instead, investors focused on guidance for Q2 core gross margin of 36%-38%, well below the 47% core gross margin Cerebras just posted in Q1. That is not a rounding error or a temporary wobble in sentiment; it is a direct signal that scaling revenue is getting more expensive than the market wanted to hear.
The valuation leaves no room for that kind of reset. CBRS carries a TickerSpark Score of 67, but the split matters: Growth is a perfect 100 and Profitability is a solid 80, while Valuation is only 40 and Momentum is 30. That profile screams expensive story stock, and expensive story stocks get repriced fast when the story shifts. With P/S at 67.26 and EV/EBITDA at 159.25, Cerebras was priced for near-perfect execution. Once management told the market full-year core gross margin would land at 38%-41% and core operating margin at negative 28% to negative 32%, perfection was off the table.
The market has already started voting on that change in narrative. CBRS is down 41.4% year to date while the Technology sector is up 26.9%, a brutal 68.3-point gap that tells you this is not just broad risk-off pressure. Even after a quarter that nearly doubled revenue, the stock could not hold the growth story because investors are now asking whether those sales translate into durable returns. That skepticism is fair when operating margin sits at negative 21.9% and ROIC is negative 3.7%, especially in a business that has already flagged dependence on a limited number of major customers and the challenge of funding infrastructure growth.
The bullish case is not hard to see. Revenue growth of 75.7% on a trailing basis is elite, EPS growth is 115.3%, and the company disclosed a multi-year OpenAI deal valued at more than $20 billion alongside an AWS partnership. Analysts have also stayed supportive, with five recent ratings all sitting in the buy camp, and peer ALAB actually trades at a similar premium with a 68.45x sales multiple. If the market only cared about top-line expansion and AI positioning, Cerebras would still look like a leadership name.
That is exactly why the selloff matters. The bulls got the revenue proof they wanted, and the stock still cracked because the market moved on to the next question. ALAB at least pairs its 115.1% revenue growth with a 26.7% net margin, while CBRS is now telling investors to expect a meaningful gross-margin step down right after its debut report. When the multiple is this rich, the burden shifts from proving demand to proving that demand is profitable enough to deserve the premium.
That leaves CBRS looking more like a stock to avoid than a dip to chase. We would rather own ALAB right now because the market is rewarding AI infrastructure stories with cleaner margin credibility, not just louder growth. Cerebras may still build a big business, but this setup says the stock got ahead of the economics.
What would change our mind is straightforward: a quarter that shows the OpenAI and AWS opportunity converting into revenue without another margin reset. Until then, the key level to respect is not a chart line but the company's own guidance range. If management is telling investors to brace for 36%-38% core gross margin next quarter, we see no reason to pay a hyper-premium multiple for hope.
